Gainers
• Miragen Therapeutics, Inc. MGEN stock surged 63.9% to $2.77 during Thursday's pre-market session. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.
• Novus Therapeutics, Inc. NVUS shares rose 33.3% to $0.80. The most recent rating by H.C. Wainwright, on November 27, is at Buy, with a price target of $2.00.
• Inovio Pharmaceuticals, Inc. INO stock increased by 15.8% to $4.76. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Vaxart, Inc. VXRT shares surged 8.2% to $0.78.
• Cleveland BioLabs, Inc. CBLI stock rose 8.1% to $2.41.
• Kadmon Holdings, Inc. KDMN stock moved upwards by 6.9% to $4.80. The most recent rating by Nomura Instinet, on January 10, is at Buy, with a price target of $10.00.
• Soligenix, Inc. SNGX shares rose 6.4% to $2.81.
• Novavax, Inc. NVAX stock increased by 3.2% to $7.06.
Losers
• Conatus Pharmaceuticals, Inc. CNAT stock plummeted 14.0% to $0.40 during Thursday's pre-market session.
• DBV Technologies, Inc. DBVT stock plummeted 8.6% to $10.36. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
• Catabasis Pharmaceuticals, Inc. CATB stock decreased by 6.3% to $5.31.
• Genprex, Inc. GNPX shares decreased by 4.4% to $1.51.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.